-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA: GRANTS ACCELERATED APPROVAL TO RYBREVANT FASPRO FOR RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA

Reuters·11/05/2026 22:34:46

Please log in to view news